These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vaccination against nicotine: an emerging therapy for tobacco dependence. Maurer P; Bachmann MF Expert Opin Investig Drugs; 2007 Nov; 16(11):1775-83. PubMed ID: 17970637 [TBL] [Abstract][Full Text] [Related]
5. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Price GA; Russell MW; Cornelissen CN Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481 [TBL] [Abstract][Full Text] [Related]
6. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli. Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752 [TBL] [Abstract][Full Text] [Related]
7. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
8. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine. Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635 [TBL] [Abstract][Full Text] [Related]
9. The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial. Wagena EJ; de Vos A; Horwith G; van Schayck CP Nicotine Tob Res; 2008 Jan; 10(1):213-8. PubMed ID: 18188762 [TBL] [Abstract][Full Text] [Related]
10. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Maurer P; Jennings GT; Willers J; Rohner F; Lindman Y; Roubicek K; Renner WA; Müller P; Bachmann MF Eur J Immunol; 2005 Jul; 35(7):2031-40. PubMed ID: 15971275 [TBL] [Abstract][Full Text] [Related]
12. Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum. de Villiers SH; Cornish KE; Troska AJ; Pravetoni M; Pentel PR Vaccine; 2013 Dec; 31(52):6185-93. PubMed ID: 24176492 [TBL] [Abstract][Full Text] [Related]
13. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit. Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339 [TBL] [Abstract][Full Text] [Related]
15. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant. Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794 [TBL] [Abstract][Full Text] [Related]
16. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies. Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734 [TBL] [Abstract][Full Text] [Related]
17. Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier. Miller KD; Roque R; Clegg CH PLoS One; 2014; 9(12):e114366. PubMed ID: 25494044 [TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection. Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585 [TBL] [Abstract][Full Text] [Related]
19. [Expecting the antinicotine vaccine]. Didilescu C Pneumologia; 2009; 58(3):177-8. PubMed ID: 19817315 [TBL] [Abstract][Full Text] [Related]
20. A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle. Hu Y; Zheng H; Huang W; Zhang C Hum Vaccin Immunother; 2014; 10(1):64-72. PubMed ID: 24091786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]